Denisa Riera
Foot & Ankle Surgery · Bridgeport, CTNPI 1356731244
Payments from drug & device makers
What this record shows
This record is dominated by food and beverage: $8,403 of the $9,430 with a category attached, or 89.1%. 42 manufacturers reported payments, led by Smith+Nephew at 27.6% of the total. Reporting peaked in 2024 at $2,715 and has fallen 62.2% since, to $1,026 in 2025.
Across 308 payments — averaging $30.62 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Smith+Nephew$3K
- Mimedx Group, Inc.$1K
- Organogenesis Inc.$841
- Paratek Pharmaceuticals, Inc.$539
- Amgen$495
- Stryker$452
- plus $3K from 36 others
What the payments were for
- Consulting fees$1001%
- Travel & lodging$92810%
- Food & beverage$8,40389%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Stravix$619
- Grafix$592
- Kerecis SurgiClose$473
- GrafixPL$355
- Apligraf$279
- InnovaMatrix AC$138
- Kerecis GraftGuide$118
- REGRANEX$110
- KRYSTEXXA$105
- SIVEXTRO$100
How this compares
$9,430 in reported general payments places this provider in the 80th percentile of 89 foot & ankle surgery providers in Connecticut.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| CiclopiroxCiclopirox Olamine | 60 | $1,805 |
| Ciclopirox | 15 | $400 |
| Ammonium Lactate | 12 | $259 |
| Doxycycline Hyclate | 17 | $161 |
| Cephalexin | 23 | $121 |
| Ciprofloxacin Hcl | 17 | $96 |
Paid to pharmacies, not to this prescriber.
Other foot & ankle surgery in Bridgeport
- Ceasar IrbyBridgeport$2K
- Thomas McDonaldEnfield$241K
- Jossie AbrahamNorwalk$152K
- Gabriel GambardellaBloomfield$99K
- David CaminearHamden$47K
- James DejesusNaugatuck$40K
- William ProbascoFairfield$26K
- Adebola AdelekeMiddletown$24K
- Rachel AlbrightDarien$14K
- Paulina PiekarskaNorwalk$13K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.